$ABBV
AI 분석생성일 May 18, 2026
AI Score
Buy$ABBV
AbbVie Inc.
$ABBVNYSEHealthcareLarge-Cap
AbbVie discovers, develops, manufactures, and sells pharmaceuticals worldwide focusing on immunology, oncology, and neuroscience.
Market Cap
$340B
Revenue (TTM)
$58.2B
+5.8%
Net Income (TTM)
$8.5B
+22.5%
EPS (TTM)
$4.82
P/E Ratio
38.5
Dividend Yield
3.2%
52-Week Range
$155-$205
Beta
0.58
Dimension Scores
Fundamental
78Technical
70Sentiment
74Risk / Reward
75Momentum
68Financial Health
Profitability
75moderate
Growth
72moderate
Liquidity
70moderate
Solvency
65moderate
Efficiency
76moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $ABBV
Free · No credit card required
면책 조항: AI 생성 분석은 교육 목적으로만 제공됩니다. 투자 조언이 아닙니다. 항상 자격을 갖춘 재무 상담사와 상담하세요.